The Developing Acceptance of Metabolomics in Customized Medicines Is One of the Key Variables Boosting the Development of the Metabolomics Market
According to a new market research report "Metabolomics Market By Product (GC, Bioinformatics, Mass Spectrometry, HPLC, UPLC, NMRS, Surface Based Mass Analysis,), Indication (Oncology, Cardiology, Inborn Errors), Application (Nutrigenomics, Toxicology, Biomarker & Drug Discovery) - Global Forecast to 2021", published by MarketDataForecast™, the market is expected to reach USD 5.14 Billion by 2021 from USD 3.68 Billion in 2016, at a CAGR of 6.9%. Metabolomics includes the employment of assorted analytical techniques for the determination of metabolites resembling spectroscopic analysis,...
View full press release